State Equity Programs

• Black people stopped and searched for drugs at almost nine times the rate of white people
• Black people convicted of cannabis possession at 11.8 times the rate of white people
• Asian people convicted of cannabis possession at 2.4 times the rate of white people
• All disparities exist despite Black and Asian people reporting lower rates of self-reported drug use than white people — confirming enforcement bias rather than use difference
• The disparity has persisted and worsened despite decades of reform discussion

• 25% of cannabis tax revenue to Restore, Reinvest, and Renew (R3) Program serving disproportionately impacted communities
• One-fifth of points in retail licence scoring for social equity applicant status
• Social Equity Fund: $50m+ in low-interest loans for equity applicants
• Automatic expungement of cannabis convictions under 30g

Most comprehensive cannabis equity framework in US. Levy implementation challenges: long delays in equity licence processing; corporate applicants filed legal challenges delaying equity window.

• Licence fee waivers for equity applicants (100% waiver)
• Three years free rent and security at city-owned facilities for equity operators
• Priority processing for equity applicants
• 1:1 ratio requirement: for every non-equity licence, one equity licence must be issued

Most generous local equity program. 1:1 ratio is the strongest structural protection against inequitable market development in any US jurisdiction. Monitor for sustainability as market matures.

• $7 million allocated to expunge cannabis offences
• Microbusiness licence category: lower barriers to entry, preference for applicants from disproportionately impacted areas
• Social equity applicant definition includes those with prior cannabis convictions or family members with prior convictions

Expungement fund is notable but $7m is inadequate for the scale of prior convictions. Microbusiness category is innovative but underfunded. Monitor for implementation pace.

• Retailers limited to three licences maximum (licence cap)
• Economic empowerment applicants receive priority processing
• Host Community Agreements require community benefits
• Social equity program with technical assistance

Three-licence cap is the closest US cannabis framework has come to Transform's licence restriction criterion. Monitor for whether psychedelic frameworks adopt similar caps.

• Retailers limited to three licences maximum
• Social equity in cannabis (SEIC) program (adopted 2022 — delayed implementation)
• Community reinvestment account

Three-licence cap adopted. SEIC implementation significantly delayed — equity provisions adopted years after initial legalisation, allowing first-mover advantage to non-equity operators.

• Business-diversity criteria in licensing scoring
• Cannabis Compliance Board social equity provisions
• Microbusiness licence category

Business-diversity criteria are weaker than set-aside or ratio models. Monitor for whether diversity criteria produce measurable ownership diversification.

• No individual or group may hold >15% of total provincial retail licences
• Prohibition on vertically integrated retail (producers cannot own retail)

15% ownership cap is the most aggressive market concentration limit in any legal cannabis jurisdiction globally. Directly addresses Transform toolkit criterion 2. Monitor for whether this model is adopted in psychedelic frameworks.

• Non-profit membership-based associations since 2001 — 23-year proof of concept
• No commercial sales permitted
• No advertising permitted
• Membership-only — not open to general public
• Local regulation varies by municipality (Barcelona, Bilbao most permissive)

The definitive proof of concept for Transform's Tier 2 model. 23 years of operation demonstrates non-profit, membership-based cannabis access is viable at scale. No equivalent psychedelic jurisdiction exists. Uruguay (pharmacy model) and Malta (cannabis association model, 2021) are companion examples.

• Licensed service centres — supervised use only
• No home use permitted under Measure 109
• Equity provisions in licensing rules (adopted 2023)
• Decriminalisation via Measure 110 (subsequently repealed 2024)

Oregon is the only active psychedelic equity framework. Equity provisions are weaker than Illinois or Oakland cannabis models — no licence caps, no set-aside ratios, no dedicated reinvestment fund. Measure 110 repeal (2024) reversed decriminalisation, demonstrating fragility of reform without equity embedding.

• Licensed healing centres — supervised use
• Personal use and gifting permitted (Tier 1 partial implementation)
• Social equity provisions in licensing rules (under development)
• Peyote excluded by name

Equity provisions still under development. No licence caps. No set-aside ratios. No dedicated reinvestment fund. Most progressive on Tier 1 access (personal use/gifting) but weakest on equity infrastructure.

The gap between Transform’s equity framework and current psychedelic regulatory practice is stark. The explicit scoring of Oregon and Colorado against all four levers and five pillars shows: Oregon meets 1.5/4 levers and 1/5 pillars; Colorado meets 1/4 levers and 1/5 pillars. Cannabis best practice (Illinois: 3/4 levers, 4/5 pillars; Oakland: 4/4 levers, 1:1 ratio) took years of advocacy and multiple legislative revision cycles to achieve. The first legal psychedelic markets in the US are structurally worse on equity than mid-tier cannabis frameworks.

The time-sensitive implication is the first-mover advantage gap. In cannabis, equity provisions adopted years after initial legalisation could not reverse first-mover advantages already established by well-capitalised non-equity operators. Every Oregon and Colorado licence issued to a non-equity operator before equity provisions are strengthened is a market position that subsequent reform cannot easily dislodge. The Oregon Measure 110 repeal (2024) demonstrates that decriminalisation without structural embedding is politically reversible.

The five reparative pillars set the standard Transform’s framework requires. Pillars 1 (recognition and accountability), 4 (collaboration and allyship), and 5 (reinvestment and global responsibility) are absent from every current US psychedelic framework. The absence of Pillar 5 directly connects to the development lens gaps in Tab 5 — the communities bearing the costs of the global drug trade are not included in the reinvestment logic of any US psychedelic framework.

We store only the name and email you enter here, and use them only to send this digest. Every email carries an unsubscribe link, which removes the address immediately.